L.L.A. Lecluse

978 total citations
10 papers, 600 citations indexed

About

L.L.A. Lecluse is a scholar working on Immunology, Economics and Econometrics and Dermatology. According to data from OpenAlex, L.L.A. Lecluse has authored 10 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 4 papers in Economics and Econometrics and 3 papers in Dermatology. Recurrent topics in L.L.A. Lecluse's work include Psoriasis: Treatment and Pathogenesis (7 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Dermatology and Skin Diseases (3 papers). L.L.A. Lecluse is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (7 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Dermatology and Skin Diseases (3 papers). L.L.A. Lecluse collaborates with scholars based in Netherlands, United States and Canada. L.L.A. Lecluse's co-authors include Phyllis I. Spuls, Jan D. Bos, Robert S. Stern, Tamar Nijsten, E.M.G.J. de Jong, R.J.B. Driessen, Menno A. de Rie, Steven O. Stapel, Martijn B. A. van Doorn and Gertjan Wolbink and has published in prestigious journals such as Journal of Investigative Dermatology, British Journal of Dermatology and Dermatology.

In The Last Decade

L.L.A. Lecluse

10 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L.L.A. Lecluse Netherlands 9 491 266 120 106 79 10 600
P.P.M. van Lümig Netherlands 15 497 1.0× 297 1.1× 123 1.0× 131 1.2× 28 0.4× 18 605
S.P. Menting Netherlands 9 504 1.0× 192 0.7× 100 0.8× 30 0.3× 40 0.5× 13 585
S. Li United States 8 593 1.2× 338 1.3× 118 1.0× 51 0.5× 21 0.3× 23 683
Jeffrey Zweegers Netherlands 14 455 0.9× 245 0.9× 99 0.8× 122 1.2× 12 0.2× 19 610
JC Prinz Germany 10 372 0.8× 182 0.7× 82 0.7× 31 0.3× 19 0.2× 10 442
Annamaria Mazzotta Italy 16 756 1.5× 448 1.7× 193 1.6× 50 0.5× 13 0.2× 29 901
Arianna Zangrilli Italy 13 432 0.9× 277 1.0× 145 1.2× 37 0.3× 8 0.1× 38 547
Ehab Mahgoub United States 12 282 0.6× 55 0.2× 208 1.7× 98 0.9× 91 1.2× 20 508
E. Nikaï United States 8 210 0.4× 143 0.5× 238 2.0× 37 0.3× 17 0.2× 15 415
D. Toth Canada 5 555 1.1× 565 2.1× 146 1.2× 54 0.5× 7 0.1× 6 800

Countries citing papers authored by L.L.A. Lecluse

Since Specialization
Citations

This map shows the geographic impact of L.L.A. Lecluse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.L.A. Lecluse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.L.A. Lecluse more than expected).

Fields of papers citing papers by L.L.A. Lecluse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.L.A. Lecluse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.L.A. Lecluse. The network helps show where L.L.A. Lecluse may publish in the future.

Co-authorship network of co-authors of L.L.A. Lecluse

This figure shows the co-authorship network connecting the top 25 collaborators of L.L.A. Lecluse. A scholar is included among the top collaborators of L.L.A. Lecluse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.L.A. Lecluse. L.L.A. Lecluse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Spuls, Phyllis I., et al.. (2014). NHG-Standaard Psoriasis (derde herziening). Huisarts en Wetenschap. 57(3). 128–135. 1 indexed citations
2.
Menting, S.P., P.P.M. van Lümig, J.M.P.A. van den Reek, et al.. (2013). Extent and Consequences of Antibody Formation Against Adalimumab in Patients With Psoriasis. JAMA Dermatology. 150(2). 130–130. 67 indexed citations
3.
Ormerod, A.D., Matthias Augustin, Christopher Baker, et al.. (2012). Challenges for Synthesising Data in a Network of Registries for Systemic Psoriasis Therapies. Dermatology. 224(3). 236–243. 30 indexed citations
4.
Lecluse, L.L.A., Emmilia A. Dowlatshahi, Jacqueline Limpens, et al.. (2011). Etanercept. Archives of Dermatology. 147(1). 79–79. 12 indexed citations
5.
Lümig, P.P.M. van, L.L.A. Lecluse, R.J.B. Driessen, et al.. (2010). Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept. British Journal of Dermatology. 163(4). 838–846. 39 indexed citations
6.
Lecluse, L.L.A., R.J.B. Driessen, Phyllis I. Spuls, et al.. (2010). Extent and Clinical Consequences of Antibody Formation Against Adalimumab in Patients With Plaque Psoriasis. Archives of Dermatology. 146(2). 127–32. 125 indexed citations
7.
Spuls, Phyllis I., et al.. (2009). How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review. Journal of Investigative Dermatology. 130(4). 933–943. 194 indexed citations
8.
Lecluse, L.L.A., et al.. (2009). Patient preferences and satisfaction with systemic therapies for psoriasis: an area to be explored. British Journal of Dermatology. 160(6). 1340–1343. 21 indexed citations
9.
Lecluse, L.L.A., Luigi Naldi, Robert S. Stern, & Phyllis I. Spuls. (2008). National Registries of Systemic Treatment for Psoriasis and the European ‘Psonet’ Initiative. Dermatology. 218(4). 347–356. 39 indexed citations
10.
Lecluse, L.L.A., Gamze Pişkin, Jan R. Mekkes, J.D. Bos, & Menno A. de Rie. (2008). Review and expert opinion on prevention and treatment of infliximab-related infusion reactions. British Journal of Dermatology. 159(3). 527–536. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026